News

Podcast

Scott Hamilton: When Fear Flips

Author(s):

Brielle Benyon

For this episode of the CURE Talks Cancer podcast, we spoke with Scott Hamilton, an Olympic gold medalist, cancer survivor and founder of the Scott Hamilton CARES Foundation

Receiving a cancer diagnosis can be terrifying—Olympic gold medalist Scott Hamilton knows that firsthand. However, after the shock wears off, it’s possible to use cancer as a motivation to do better in the world. That’s what Scott Hamilton did by starting the Scott Hamilton CARES foundation, which is dedicated to improving the future of cancer care.

In this week’s episode, we spoke with Hamilton about his personal bouts with testicular cancer and a brain tumor, as well as losing his mother to breast cancer. The former professional ice skater also touches upon why he wanted to be involved in CURE’s 2018 MPN Heroes event.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of man with text.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Related Content
Image of breast.
July 17th 2025

Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer

Ryan Scott
The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
July 14th 2025

The Power of Suggestion in Breast Cancer Prevention

Bonnie Annis
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Breast cancer care differs around the world, revealing urgent unmet needs: © stock.adobe.com.
July 9th 2025

Layers of Pain: Decoding the Multifaceted Toxicity of Breast Cancer

Dr. Dinesh Raj Neupane
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.
Experts discuss treatment options for those with ER-positive, HER2-negative stage 4 breast cancer: © stock.adobe.com.
July 9th 2025

Understanding Therapeutic Options for ER+/HER2- Metastatic Breast Cancer

Kristie L. Kahl
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.